Last reviewed · How we verify
Iritis
Approved treatments
- Lotemax · Bausch Health
- Fml · AbbVie
- Medrifar · AbbVie
- Cortone
- Lotemax · Tufts Medical Center
- Decadron · Generic (originally Merck)
- Cortef · Generic (originally Merck/Upjohn)
- Flarex · Harrow Health
- Loteprednol Etabonate · Bausch And Lomb
- Cortisol · University of Zurich
- Prelone · Generic (originally Schering)
- prednisolon · Hannover Medical School
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Iritis patent landscape — cliff calendar, originator estates, attackable patents
- Iritis treatment landscape brief
- Iritis treatment updates RSS
Frequently asked questions about Iritis
What drugs treat Iritis?
Tracked treatments include Lotemax, Fml, Medrifar, Cortone, Decadron, Cortef, Flarex, Loteprednol Etabonate.
What is the treatment for Iritis?
Standard treatment for Iritis includes Lotemax, Fml, Medrifar, Cortone, Decadron. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Iritis patent cliff · Iritis CI report
- Treatment: Lotemax · Bausch Health
- Treatment: Fml · AbbVie
- Treatment: Medrifar · AbbVie
- Treatment: Cortone
- Treatment: Lotemax · Tufts Medical Center
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing